Celularity Inc

Celularity Inc, operating under the SPAC ticker GXGX on Nasdaq, filed a Form 10-Q with the Securities and Exchange Commission on August 13, 2020. GXGX is a special purpose acquisition company that came to market in 2020 targeting opportunities in the healthcare and biotechnology sector, with particular emphasis on cell therapy and life sciences. The filing reflects the company's operational status during the period immediately following its IPO and ahead of its announced business combination with Celularity, a clinical-stage company focused on developing placenta-derived allogeneic cell therapies. The 10-Q provides a quarterly financial snapshot of the SPAC entity at that stage of its lifecycle. Sign up for SpacDesk to access the full filing history, deal timeline, and analytics for GXGX and the broader SPAC universe.